Nephros (NEPH) Shares Outstanding (Diluted Average) (2010 - 2026)

Nephros' Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $11.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 3.53% year-over-year to $11.0 million; the TTM figure through Mar 2026 stood at $11.0 million (up 3.53% YoY), while the FY2025 annual figure was $11.0 million, up 3.45% from the prior year.
• Shares Outstanding (Diluted Average) was $11.0 million for Q1 2026 at Nephros, roughly flat from $11.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $11.0 million in Q3 2025 to a low of $10.3 million in Q2 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $10.6 million across 5 years, with a median of $10.5 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) rose 0.31% in 2023, then rose 4.96% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $10.3 million in 2022, then grew by 0.86% to $10.4 million in 2023, then advanced by 2.08% to $10.6 million in 2024, then increased by 3.45% to $11.0 million in 2025, then increased by 0.21% to $11.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $11.0 million (Q1 2026), $11.0 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.